Wei Li
Impact in
-
- Diabetes Treatment and Management
- Physiology top 1%
- Nutrition and Health in Aging
Papers in
-
- Metabolism, Diabetes, and Cancer 13
- Physiology 71
- Nutrition and Health in Aging 32
- Telomeres, Telomerase, and Senescence 13
- Co-authors
- Robert R. Edelman (5 shared papers)Warren J. Manning (2 shared papers)Fan Ping (59 shared papers)Yuxiu Li (61 shared papers)Huabing Zhang (56 shared papers)Lingling Xu (43 shared papers)James F. List (1 shared paper)Afshin Salsali (1 shared paper)
- Journals
- Frontiers in Endocrinology (15 papers)Medicine (10 papers)PLoS ONE (10 papers)Diabetes Research and Clinical Practice (8 papers)Frontiers in Immunology (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Li
486 papers receiving 9.7k citations
Wei Li's Hit Papers
Peers
Comparison fields: 5 of 196
- Endocrinology, Diabetes and Metabolism 1.2k
- Physiology 1.2k
- Cancer Research 632
- Radiology, Nuclear Medicine and Imaging 949
- Nephrology 265
Countries citing papers authored by Wei Li
This map shows the geographic impact of Wei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Li more than expected).
Fields of papers citing papers by Wei Li
This network shows the impact of papers produced by Wei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Li. The network helps show where Wei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 510 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 402 | |
| 2 | Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy Hit paper breakdown → | 2012 | 347 |
| 3 | 2012 | 246 | |
| 4 | Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells Hit paper breakdown → | 2021 | 226 |
| 5 | Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases Hit paper breakdown → | 2022 | 195 |
| 6 | 1996 | 190 | |
| 7 | 2020 | 175 | |
| 8 | 2020 | 146 | |
| 9 | 2015 | 139 | |
| 10 | 2005 | 133 | |
| 11 | 2011 | 122 | |
| 12 | 2017 | 119 | |
| 13 | Effectiveness of virtual reality in nursing education: a systematic review and meta-analysis Hit paper breakdown → | 2023 | 113 |
| 14 | 1993 | 105 | |
| 15 | 2020 | 105 | |
| 16 | 2020 | 99 | |
| 17 | 2018 | 99 | |
| 18 | 2017 | 98 | |
| 19 | 2016 | 93 | |
| 20 | 2016 | 93 |
About Wei Li
Wei Li is a scholar working on Molecular Biology, Physiology, Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 510 papers that have together received 9.8k indexed citations. Recurring topics across this work include Nutrition and Health in Aging (32 papers), Diabetes Treatment and Management (15 papers), Liver Disease Diagnosis and Treatment (15 papers), Diabetes Management and Research (14 papers), Metabolism, Diabetes, and Cancer (13 papers), Telomeres, Telomerase, and Senescence (13 papers), Gestational Diabetes Research and Management (12 papers) and Neuroendocrine Tumor Research Advances (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Physiology (1.2k citations), Cancer Research (632 citations), Radiology, Nuclear Medicine and Imaging (949 citations) and Nephrology (265 citations). Wei Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Robert R. Edelman, Warren J. Manning, Fan Ping, Yuxiu Li, Huabing Zhang, Lingling Xu, James F. List, Afshin Salsali, Julio Rosenstock and Marisa L. Vico. Their work appears in journals such as Frontiers in Endocrinology, Medicine, PLoS ONE, Diabetes Research and Clinical Practice and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.